Company intelligence / Profile preview

Gense Technologies

Hong Kong, Hong Konggensetechnologies.com ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

Gense Technologies has developed and commercialized "mediscan," a portable AI-powered medical imaging device for non-invasive health screening of organs such as the liver, lungs, kidneys, and heart. The device provides real-time results for early detection of chronic diseases and can be used at home or in clinics. It adheres to international safety standards (ISO 13485) and has been certified for sale in Hong Kong. Clinical trials are ongoing with academic partners.

Therapeutic areas: PulmonologyOncologyImmunologyGastroenterologyCardiovascularNephrology
Modalities: Device
Industry: Medical Imaging

Partnerships

Academic partnerships with multiple Hong Kong universitiesover eight clinical trial/engineering collaborations with professors

Beyond the preview

Go deeper on Gense Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gense Technologies.

Explore the full profile